Pfizer CFO D'Amelio to retire after 15 years at company

  • 📰 Reuters
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Pfizer Inc said on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company.

Frank D'Amelio, Executive Vice President, Business Operations and Chief Financial Officer of Pfizer Inc., arrives at Portcullis House to attend a parliamentary business and enterprise committee hearing on the future of AstraZeneca, in central London, May 13, 2014. REUTERS/Andrew Winningsaid on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company.

The drugmaker has started an external search for the successor of D'Amelio, who also served as executive vice president of global supply. During his tenure, Pfizer slimmed down its business through sales to focus on its newer, patent-protected portfolio of profitable drugs such as cancer treatment Ibrance.

D'Amelio played crucial roles in the company's 2011 sale of its capsule-making unit to private equity firm KKR & Co

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer to allow generic versions of its COVID pill in 95 countriesPfizer Inc said on Tuesday it will allow generic manufacturers to supply its experimental antiviral COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).
Source: Reuters - 🏆 2. / 97 Read more »

Pfizer agrees to let other companies make its Covid pill to allow broader global accessDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population.
Source: NBCNews - 🏆 10. / 86 Read more »

Pfizer agrees to let other companies make its COVID-19 pillDrugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. “It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the Medicines Patent Pool, said.
Source: YahooNews - 🏆 380. / 59 Read more »

Pfizer signs license agreement to allow broader global access to its experimental Covid-19 antiviral pillPfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental Covid-19 pill. Gosh they are making so much money.... That's the general idea isn't it? You can keep your nauseating pill Wish those on here having a go would actually read it first rather than making themselves look daft Test on the poor ...hah
Source: CNN - 🏆 4. / 95 Read more »

Pfizer Licenses Promising Covid-19 Pill to U.N.-Backed NonprofitPfizer is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. Because Ivermectine was too cheap and already proven to be effective...
Source: WSJ - 🏆 98. / 63 Read more »

Pfizer agrees to let other companies make its COVID-19 pillLONDON (AP) — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population. mikewsyx6 I ran across a documentary called 'Covid-19, Race for the Vaccine' about Pfizer's efforts to get the vaccine out. It's well worth watching. Glad they're willing to share this new pill to help people, not their bottom line. kxly4news This is all turning out to be very lucrative for pfizer. Good thing they got all that money and support from Operation Warp Speed huh? Thank you pfizer
Source: AP - 🏆 728. / 51 Read more »